Literature DB >> 6966679

Coded-aperture imaging of the heart.

W L Rogers, K F Koral, R Mayans, P F Leonard, J H Thrall, T J Brady, J W Keyes.   

Abstract

Coded-aperture imaging of the heart combines the advantages of tomography with good sensitivity, high resolution, and accurate size scaling. Since the images are multiplexed, the method may be adapted to small, portable cameras for bed-side use without sacrificing image resolution. A new coded aperture designed especially for cardiac imaging has been constructed and tested. This aperture incorporates significant improvements over previous designs. Longitudinal tomograms are calculated at 1-cm intervals using a modified ART algorithm. Experimental lateral resulution at 140 keV with a portable scintillation camera is 3.8 mm FWHM at 4 cm, and 7.8 mm FWHM at 12 cm. Dpth resolution determined from a sloping line source is 1.1 cm FWHM at 4 cm, and 2.9 cm at 12 cm. The calculated point-source sensitivities in air at 4 cm and 12 cm, respectively, are 20 and 8 cps/microCi. Images of good diagnostic quality have been obtained in phantoms and in a dog model of acute myocardial infarction, using thallium-201, technetium-99m pyrophosphate, and gated ventricular blood-pool imaging with Tc-labeled red blood cells. Preliminary studies in humans confirm the good results in animals.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6966679

Source DB:  PubMed          Journal:  J Nucl Med        ISSN: 0161-5505            Impact factor:   10.057


  3 in total

1.  Recent advances in BazookaSPECT: Real-time data processing and the development of a gamma-ray microscope.

Authors:  Brian W Miller; Harrison H Barrett; Lars R Furenlid; H Bradford Barber; Robert J Hunter
Journal:  Nucl Instrum Methods Phys Res A       Date:  2008-06-11       Impact factor: 1.455

2.  Optimization of coded aperture radioscintigraphy for sentinel lymph node mapping.

Authors:  Hirofumi Fujii; John D Idoine; Sylvain Gioux; Roberto Accorsi; David R Slochower; Richard C Lanza; John V Frangioni
Journal:  Mol Imaging Biol       Date:  2012-04       Impact factor: 3.488

Review 3.  Selecting the optimal immunotherapy regimen in driver-negative metastatic NSCLC.

Authors:  Michael J Grant; Roy S Herbst; Sarah B Goldberg
Journal:  Nat Rev Clin Oncol       Date:  2021-06-24       Impact factor: 66.675

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.